年轻结直肠癌患者的胚系遗传特征
该回顾性研究分析了1998至2015年间单中心收治的430例50岁以下结直肠癌患者,发现约1/5携带与癌症相关的胚系突变,其中近半数缺乏典型综合征临床病史,作者认为所有年轻结直肠癌患者应考虑多基因胚系检测。
要点
- 430例年轻结直肠癌中,111例(26%)有一级亲属结直肠癌史。
- 315例接受临床胚系测序者中,79例检出遗传性癌症综合征相关突变。
- 117例临床评估无信息者经多基因panel测序,6例(5%)检出可干预胚系变异。
核心结论
- 约1/5的50岁以下结直肠癌患者携带与癌症相关的胚系突变,其中近半数缺乏通常与所识别综合征相关的临床病史。
- 作者认为所有年轻结直肠癌患者应考虑进行多基因癌症panel胚系检测。
研究设计与样本
- 回顾性研究,纳入1998年至2015年间在单一三级癌症中心临床遗传学服务评估的50岁以下确诊结直肠癌个体。
- 收集患者病史、肿瘤表型及胚系DNA测序结果;对临床评估无信息者的胚系DNA样本使用研究性下一代测序多基因panel进行(重)测序。
主要发现
- 430例年轻结直肠癌中,111例(26%)有一级亲属结直肠癌。
- 41例(10%)肿瘤有错配修复缺陷的组织学证据。
- 315例接受临床胚系测序者中,79例有遗传性癌症综合征相关突变,21例为意义未明变异。
- 56例有Lynch综合征相关致病性变异(MSH2突变25例、MLH1突变24例、MSH6突变5例、PMS2突变2例),10例有家族性腺瘤性息肉病相关致病性变异。
- 13例有其他癌症相关基因突变(MUTYH 8例、SMAD4 2例、BRCA1 1例、TP53 1例、CHEK2 1例),均经多基因panel检测发现。
临床怎么用
- 作者认为所有年轻结直肠癌患者应考虑进行多基因癌症panel胚系检测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The incidence of colorectal cancer (CRC) in individuals younger than 50 years is increasing. We sought to ascertain the proportion of young CRC cases associated with genetic predisposition. METHODS: We performed a retrospective study of individuals diagnosed with CRC at an age younger than 50 years, evaluated by the clinical genetics service at a single tertiary care cancer center from 1998 through 2015. We collected data on patient histories, tumor phenotypes, and results of germline DNA sequencing. For subjects with uninformative clinical evaluations, germline DNA samples were (re)sequenced using a research-based next-generation sequencing multigene panel. The primary outcome was identification of a pathogenic germline mutation associated with cancer predisposition. RESULTS: Of 430 young CRC cases, 111 (26%) had a first-degree relative with CRC. Forty-one of the subjects with CRC (10%) had tumors with histologic evidence for mismatch repair deficiency. Of 315 subjects who underwent clinical germline sequencing, 79 had mutations associated with a hereditary cancer syndrome and 21 had variants of uncertain significance. Fifty-six subjects had pathogenic variants associated with Lynch syndrome (25 with mutations in MSH2, 24 with mutations in MLH1, 5 with mutations in MSH6, and 2 with mutations in PMS2) and 10 subjects had pathogenic variants associated with familial adenomatous polyposis. Thirteen subjects had mutations in other cancer-associated genes (8 in MUTYH, 2 in SMAD4, 1 in BRCA1, 1 in TP53, and 1 in CHEK2), all identified through multigene panel tests. Among 117 patients with uninformative clinical evaluations, next-generation sequence analysis using a multigene panel detected actionable germline variants in 6 patients (5%). Only 43 of the 85 subjects with germline mutations associated with a hereditary cancer syndrome (51%) reported a CRC diagnosis in a first-degree relative. CONCLUSIONS: Approximately 1 in 5 individuals diagnosed with CRC at age younger than 50 years carries a germline mutation associated with cancer; nearly half of these do not have clinical histories typically associated with the identified syndrome. Germline testing with multigene cancer panels should be considered for all young patients with CRC.
引用
- Stoffel EM, Koeppe E, Everett J, et al. Germline Genetic Features of Young Individuals With Colorectal Cancer. Gastroenterology. 2017. PMID: 29146522. doi:10.1053/j.gastro.2017.11.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。